SAN DIEGO, Dec. 20, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), a leading hemp industry innovator and its portfolio company CanChew Biotechnologies are pleased to announce that packages of its free product trial market survey of CanChew gum shipped to participants yesterday in order to arrive before the Holiday.
In anticipation of their product feedback, participating individuals will receive a free 30-day supply of the Functional CBD gum. The Company is focused on gaining market intelligence for upcoming product offerings and looks forward to gaining responses from participants with regard to the appearance, branding andtaste of the gum.
Ted Caligiuri, President/CEO, Medical Marijuana, Inc., is excited to announce these shipments. "We have been working toward this initial shipment of product for this free trial market survey for over 6 months. This is a great milestone for this exciting Functional CBD Gum product line."
Participants will receive a minimum one-month supply of the Functional CBD Gum, blister packed in 8 count packages. Three different versions of the gum are being distributed including non-coated, base coated and hard coated. Three different brand name logos, three different packaging options and three different color schemes will be presented to participants. Feedback for each option will be specifically tracked and summarized to provide the company with valuable direction in going to market with the Functional CBD Gum.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company's website:
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor Relations Contact:
Stuart T. Smith
SOURCE Medical Marijuana, Inc.
Source: PR Newswire (December 20, 2012 - 9:27 AM EST)